Intraoperative risk of bleeding and its prevention during transcervical myomectomy

In this study clinical, functional and morphological assessment of the effectiveness of synthetic analogue of vasopressin (terlipressin) has been made. The aim of the study was to assess study drug prevention efficasy of excessive bleeding during hysteroscopic myomectomy in patients with submucosal...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaminsky V.V., Dunaevska V.V., Medvediev M.V.
Format: Article
Language:English
Published: Dnipro State Medical University 2014-09-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://medpers.dsma.dp.ua/issues/2014/N3/44-51.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846098309359337472
author Kaminsky V.V.
Dunaevska V.V.
Medvediev M.V.
author_facet Kaminsky V.V.
Dunaevska V.V.
Medvediev M.V.
author_sort Kaminsky V.V.
collection DOAJ
description In this study clinical, functional and morphological assessment of the effectiveness of synthetic analogue of vasopressin (terlipressin) has been made. The aim of the study was to assess study drug prevention efficasy of excessive bleeding during hysteroscopic myomectomy in patients with submucosal uterine leiomyoma. In 19 women with uterine leiomyoma 15 minutes prior to surgery terlipressin was administered in para¬cervical route in the dosage 0.6 mg in 10 ml of normal saline. In the comparison group, which was also consisted of 19 women in the presence of significant blood loss during myoma resection intravenous oxytocin was used. The use of terlipressin helped to reduce the volume of blood loss during surgery almost by 2 times, reduced the duration of surgery and the risk of postoperative complications. On the basis of the ultrasonic doppler blood flow studies in uterine vessels, morphological and immunohistochemical studies of hemocapillars density in removed myoma nodules it was found that terlipressin contributes significantly to reduction of the number of functioning blood vessels and also to reduction of blood flow in all parts of the vascular system both in uterus and in leiomyoma, whereas oxytocin was not observed to decrease myometrium perfusion. It conclusion the study results showed that terlipressin use is the most effective method of prevention of excessive blood loss during hysteroscopic myoma resection.
format Article
id doaj-art-e9d3485adb7847b9bfcce9b3392236a5
institution Kabale University
issn 2307-0404
2307-0404
language English
publishDate 2014-09-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-e9d3485adb7847b9bfcce9b3392236a52025-01-02T01:25:45ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042307-04042014-09-011934451Intraoperative risk of bleeding and its prevention during transcervical myomectomyKaminsky V.V.0Dunaevska V.V.1Medvediev M.V. 2Shupyk National medical academy of postgraduate educationShupyk National medical academy of postgraduate educationSE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»In this study clinical, functional and morphological assessment of the effectiveness of synthetic analogue of vasopressin (terlipressin) has been made. The aim of the study was to assess study drug prevention efficasy of excessive bleeding during hysteroscopic myomectomy in patients with submucosal uterine leiomyoma. In 19 women with uterine leiomyoma 15 minutes prior to surgery terlipressin was administered in para¬cervical route in the dosage 0.6 mg in 10 ml of normal saline. In the comparison group, which was also consisted of 19 women in the presence of significant blood loss during myoma resection intravenous oxytocin was used. The use of terlipressin helped to reduce the volume of blood loss during surgery almost by 2 times, reduced the duration of surgery and the risk of postoperative complications. On the basis of the ultrasonic doppler blood flow studies in uterine vessels, morphological and immunohistochemical studies of hemocapillars density in removed myoma nodules it was found that terlipressin contributes significantly to reduction of the number of functioning blood vessels and also to reduction of blood flow in all parts of the vascular system both in uterus and in leiomyoma, whereas oxytocin was not observed to decrease myometrium perfusion. It conclusion the study results showed that terlipressin use is the most effective method of prevention of excessive blood loss during hysteroscopic myoma resection.http://medpers.dsma.dp.ua/issues/2014/N3/44-51.pdfuterine leiomyomaterlipressinblood losshysteroscopy
spellingShingle Kaminsky V.V.
Dunaevska V.V.
Medvediev M.V.
Intraoperative risk of bleeding and its prevention during transcervical myomectomy
Medičnì Perspektivi
uterine leiomyoma
terlipressin
blood loss
hysteroscopy
title Intraoperative risk of bleeding and its prevention during transcervical myomectomy
title_full Intraoperative risk of bleeding and its prevention during transcervical myomectomy
title_fullStr Intraoperative risk of bleeding and its prevention during transcervical myomectomy
title_full_unstemmed Intraoperative risk of bleeding and its prevention during transcervical myomectomy
title_short Intraoperative risk of bleeding and its prevention during transcervical myomectomy
title_sort intraoperative risk of bleeding and its prevention during transcervical myomectomy
topic uterine leiomyoma
terlipressin
blood loss
hysteroscopy
url http://medpers.dsma.dp.ua/issues/2014/N3/44-51.pdf
work_keys_str_mv AT kaminskyvv intraoperativeriskofbleedinganditspreventionduringtranscervicalmyomectomy
AT dunaevskavv intraoperativeriskofbleedinganditspreventionduringtranscervicalmyomectomy
AT medvedievmv intraoperativeriskofbleedinganditspreventionduringtranscervicalmyomectomy